1-13 of 13
kinase inhibitors
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Relapsed CLL: sequencing, combinations, and novel agents

Jennifer R. Brown
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 248–255.
https://doi.org/10.1182/asheducation-2018.1.248
Published: 2018
Journal Articles

Optimizing frontline therapy of CLL based on clinical and biological factors

Kirsten Fischer, Michael Hallek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 338–345.
https://doi.org/10.1182/asheducation-2017.1.338
Published: 2017
Journal Articles

Patterns of resistance to B cell–receptor pathway antagonists in chronic lymphocytic leukemia and strategies for management

Jennifer A. Woyach
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 355–360.
https://doi.org/10.1182/asheducation-2015.1.355
Published: 2015
Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.
https://doi.org/10.1182/asheducation-2015.1.368
Published: 2015
Journal Articles

B-cell receptor pathway modulators in NHL

Kristie A. Blum
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 82–91.
https://doi.org/10.1182/asheducation-2015.1.82
Published: 2015
Journal Articles

BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma

Adrian Wiestner
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 125–134.
https://doi.org/10.1182/asheducation-2014.1.125
Published: 2014
Journal Articles

Monitoring after successful therapy for chronic myeloid leukemia

Susan Branford
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 105–110.
https://doi.org/10.1182/asheducation.V2012.1.105.3798223
Published: 2012
Journal Articles

Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia

Adrian Wiestner
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 88–96.
https://doi.org/10.1182/asheducation.V2012.1.88.3801172
Published: 2012
Journal Articles

Minimal Residual Disease and Discontinuation of Therapy in Chronic Myeloid Leukemia: Can We Aim at a Cure?

Junia V. Melo, David M. Ross
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 136–142.
https://doi.org/10.1182/asheducation-2011.1.136
Published: 2011
Journal Articles

Novel Agents in CML Therapy: Tyrosine Kinase Inhibitors and Beyond

Junia V. Melo, Charles Chuah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 427–435.
https://doi.org/10.1182/asheducation-2008.1.427
Published: 2008
Journal Articles

Medical Management of CML

Neil P. Shah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 371–375.
https://doi.org/10.1182/asheducation-2007.1.371
Published: 2007
Journal Articles

ABL Kinase Inhibitor Therapy for CML: Baseline Assessments and Response Monitoring

Timothy Hughes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 211–218.
https://doi.org/10.1182/asheducation-2006.1.211
Published: 2006
Journal Articles

Defining and Managing Imatinib Resistance

Michael J. Mauro
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 219–225.
https://doi.org/10.1182/asheducation-2006.1.219
Published: 2006